MISSION
Wake Forest University School of Medicine · Department of Urology
CONCEPT-PCa 2026: A Global Consensus
CONsensus for Clinical Evaluation and Precision Therapeutics in Prostate Cancer
CONCEPT-PCa 2027 Global Consensus Conference
CONFERENCE DATES
May 18-19, 2027
FORMAT
Invite Only
MD / Ph.D / APP / Industry
VENUE
The Millennium Event Center
101 W. 5th Street, Winston-Salem, NC 27101
On behalf of the organizing committee, it is a pleasure to announce a truly global consensus meeting including key opinion leaders from all over the world brought together to discuss and evaluate recommendations in Prostate Cancer care. Surgical guidelines rely on published evidence that may lack evolving concepts and techniques. The CONCEPT-PCa 2027 Global Consensus Conference employs a rigorous modified Delphi process, combining the best available literature with structured expert opinion from a geographically diverse, multidisciplinary panel.
Through 18 specialized scientific committees spanning uro-oncology, radiation oncology, medical oncology, imaging, and patient-reported outcomes, this conference will produce actionable, pragmatic guidelines for patients with varied disease phenotypes, specific risk factors, and predisposition to therapeutic complications. Each committee will apply a PICOS-based scoping or systematic review, combined with a modified Delphi process for clinical scenarios lacking published evidence — spanning the complete prostate cancer care continuum to be submitted for publication in a high impact medical journal.
Invited Participants Include:
- Global key opinion leaders in the field of Prostate Cancer
- Fellows and young researchers in the field
- Representatives from companies and foundations seeking to provide evidence-based treatment options for Prostate Cancer
- Patient support group for patient-reported outcomes development.
Consensus Development
Modified Delphi process applied to scoping and systematic reviews across 18 scientific committess, with structured discussion at the in-person meeting.
Clinical Scope
Screening through survivorship — screening, diagnosis, prognostication, therapeutic indications, techniques, PROs, and complication mitigation.
Research Agenda
Identification of major unanswered clinical questions and establishment of an international research agenda, including optimized collaborative trial design.
Publication
A special issue in a high impact medical journal to follow the conference.
ORGANIZING COMMITTEE
International leadership
across disciplines and continents
Selected based on published body of work, expertise, and contributions across all aspects of prostate cancer management.
Conference Leadership
Dr. Soroush Rais-Bahrami, MD, MBA, FACS
William H. Boyce Endowed Chair in Urology
Wake Forest University School of Medicine
Dr. Gopal Badlani, MD, FACS
Professor of Urology, Urogynecology, Regenerative Medicine
Wake Forest University School of Medicine
CO-ORDINATOR, DELPHI REVIEW PROCESS
PD
Dr. Philip Dahm, MD, MHSc
PROF OF UROLOGY, PROGRAM DIRECTOR & UROLOGY VICE CHAIR OF EDUCATION AND VETERAN AFFAIRS
University of Minnesota
QT
Dr. Quoc-Dien Trinh, MD
PROFESSOR AND CHAIR, DEPARTMENT OF UROLOGY
University of Pittsburgh School of Medicine
Organizing Core
Peter Pinto NCI · Adam Kibel SUO · Simone Crivelaro SURS · Ardeshir Rastinehad · Samir Taneja Focal Therapy · Lawrence Klotz World Oncology · Mark Emberton NICE · Nathan Lawrentschuk UAA · Francesco Montorsi EAU · Alberto Briganti EUO · Paul Nguyen NRG GU · Andrew Armstrong Duke · Nancy Dawson Georgetown · Baris Turkbey RSNA/SAR · David Daggett Patient PROs
In Attendance
Dave Penson AUA Secretary · Arnulf Stenzl EAU Secretary · Hamilton Zampoli CAU Secretary
Scientific Committees
18 committees · one consensus
Each committee applies a PICOS-based scoping or systematic review, combined with a modified Delphi process for clinical scenarios lacking published evidence — spanning the complete prostate cancer care continuum.
01
Screening
Early Detection
Co-Chairs
Dan Lin / Caroline Moore
02
Diagnosis
Workup
Co-Chairs
Mark Emberton / Baris Turkbey
03
Shared Decision Making/Prognostication
Counseling
Co-Chairs
Peter Carroll / Ganesh Palapattu
04
Active Surveillance
Conservative Management
Co-Chairs
Laurence Klotz / Peter Pinto
05
Focal Therapy
Minimally Invasive
Co-Chairs
Ardeshir Rastinehad / Steve Canfield / Samir Taneja
06
Surgical Therapy
Local Treatment
Co-Chairs
Alberto Briganti / Jihad Kaouk / Simone Crivellero
07
Primary Radiation Therapy
Local Treatment
Co-Chairs
Jason Efstathiou / Deborah Citrin
08
Recurrence After Primary Therapy or XRT therapy
Post-Treatment
Co-Chairs
Joelle Hamilton / Minhaj Siddiqui
09
Hormone Therapy
Systemic Therapy
Co-Chairs
Neal Shore / Oliver Sartor
10
HORMONE REFRACTORY PCa
Advanced Disease
Co-Chairs
Martin Gleave / Adam Kibel
11
Functional Complications ED
Functional Outcomes
Co-Chairs
Arthur Burnett / Rafael Coehlo
12
Urinary Continence after primary RP/RT therapy
Functional Outcomes
Co-Chairs
Jasprit Sandhu / Francesco Montorsi
13
Patient Reported Outcomes
Quality of Life
Co-Chairs
Christopher Saigal / Danial Barocas / David Daggett
14
Registry Analysis & Gaps in the field
Research Infrastructure
Co-Chairs
Ted Skolaras / Matt Cooperberg
15
Survivorship
Long-Term Care
Co-Chairs
Ali Kasraian / Drew Peterson
16
USE OF TESTOSTERONE IN PCa
Urologic Oncology
Co-Chairs
John Mulhall / Andrea Salonia
17
Prostate Cancer Risk of Metastasis
Pathology / Risk
Co-Chairs
Scott Eggener / Jennifer Gordetsky
18
Industry/Education and Innovation
Industry / Education
Co-Chairs
Neil Fleshner / Soroush Rais-Bahrami
Logistics & Participation
Everything you need to know
DATES
May 18 - 19, 2027
A two-day intensive in-person consensus conference
VENUE
The Millennium Event Center
101 W. 5th Street, Winston-Salem, NC 27101
TRAVEL
Conference covers lodging, registration, and meals. Travel to and from - the conference is self-funded by attendees. Shuttle services provided to and from Greensboro, NC airport only.
REGISTRATION
Invite Only
Limited to MD, Ph.D, APP, and industry representatives with active interest in the field. Invitation required for registration.
ATTENDEE HOTEL
Embassy Suites by Hilton Winston Salem
Address: 460 N Cherry St, Winston-Salem, NC 27101
FUNDING
R13 & Industry
R13NIH/NIDDK grant application in progress. Industry Sponsorship provided
PROGRAM
Program details coming soon.
CONCEPT-PCa 2027 Program
The full scientific program will be published following the completion of committee assignments and Delphi coordination. Registered attendees will receive the detailed agenda by email prior to the conference.
VENUE
The Millennium Event Center
Event Venue in the Heart of Winston-Salem
101 W. 5th Street
Winston-Salem, NC 27101
AFFILIATES
In collaboration with leading urologic and oncologic organizations worldwide
SPONSORS
TBD